HUMAN CHROMOSOME-12 IS REQUIRED FOR OPTIMAL INTERACTIONS BETWEEN TAT AND TAR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN RODENT CELLS

被引:82
作者
ALONSO, A
DERSE, D
PETERLIN, BM
机构
[1] UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[3] NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702
[4] UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1128/JVI.66.7.4617-4621.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Levels of trans activation of the human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR) by the virally encoded transactivator Tat show marked species-specific differences. For example, levels of transactivation observed in Chinese hamster ovary (CHO) rodent cells are 10-fold lower than those in human cells or in CHO cells that contain the human chromosome 12. Thus, the human chromosome 12 codes for a protein or proteins that are required for optima Tat activity. Here, the function of these cellular proteins was analyzed by using a number of modified HIV-1 LTRs and Tats. Neither DNA-binding proteins that bind to the HIV-1 LTR nor proteins that interact with the activation domain of Tat could be implicated in this defect. However, since species-specific differences were no longer observed with hybrid proteins that contain the activation domain of Tat fused to heterologous RNA-binding proteins, optimal interactions between Tat and the trans-acting responsive RNA (TAR) must depend on this factor(s).
引用
收藏
页码:4617 / 4621
页数:5
相关论文
共 59 条
[1]   CYTOMEGALOVIRUS ACTIVATES TRANSCRIPTION DIRECTED BY THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BARRY, PA ;
PRATTLOWE, E ;
PETERLIN, BM ;
LUCIW, PA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :2932-2940
[2]   TAR-INDEPENDENT ACTIVATION OF THE HIV-1-LTR - EVIDENCE THAT TAT REQUIRES SPECIFIC REGIONS OF THE PROMOTER [J].
BERKHOUT, B ;
GATIGNOL, A ;
RABSON, AB ;
JEANG, KT .
CELL, 1990, 62 (04) :757-767
[3]   IDENTIFICATION OF LENTIVIRUS TAT FUNCTIONAL DOMAINS THROUGH GENERATION OF EQUINE INFECTIOUS-ANEMIA VIRUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT GENE CHIMERAS [J].
CARROLL, R ;
MARTARANO, L ;
DERSE, D .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3460-3467
[4]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT ACTIVITY BY COEXPRESSION OF HETEROLOGOUS TRANS ACTIVATORS [J].
CARROLL, R ;
PETERLIN, BM ;
DERSE, D .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2000-2007
[5]   DNA-BINDING OF THE MOUSE CLASS-II MAJOR HISTOCOMPATIBILITY CCAAT FACTOR DEPENDS ON 2 COMPONENTS [J].
CELADA, A ;
MAKI, RA .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) :3097-3100
[6]   A MINIMAL LENTIVIRUS TAT [J].
DERSE, D ;
CARVALHO, M ;
CARROLL, R ;
PETERLIN, BM .
JOURNAL OF VIROLOGY, 1991, 65 (12) :7012-7015
[7]   HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN BINDS TRANS-ACTIVATION-RESPONSIVE REGION (TAR) RNA INVITRO [J].
DINGWALL, C ;
ERNBERG, I ;
GAIT, MJ ;
GREEN, SM ;
HEAPHY, S ;
KARN, J ;
LOWE, AD ;
SINGH, M ;
SKINNER, MA ;
VALERIO, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :6925-6929
[8]   HIV-1 TAT PROTEIN STIMULATES TRANSCRIPTION BY BINDING TO A U-RICH BULGE IN THE STEM OF THE TAR RNA STRUCTURE [J].
DINGWALL, C ;
ERNBERG, I ;
GAIT, MJ ;
GREEN, SM ;
HEAPHY, S ;
KARN, J ;
LOWE, AD ;
SINGH, M ;
SKINNER, MA .
EMBO JOURNAL, 1990, 9 (12) :4145-4153
[9]   EQUINE INFECTIOUS-ANEMIA VIRUS TAT - INSIGHTS INTO THE STRUCTURE, FUNCTION, AND EVOLUTION OF LENTIVIRUS TRANSACTIVATOR PROTEINS [J].
DORN, P ;
DASILVA, L ;
MARTARANO, L ;
DERSE, D .
JOURNAL OF VIROLOGY, 1990, 64 (04) :1616-1624
[10]   FUNCTIONAL COMPARISON OF THE BASIC DOMAINS OF THE TAT PROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 IN TRANS ACTIVATION [J].
ELANGOVAN, B ;
SUBRAMANIAN, T ;
CHINNADURAI, G .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2031-2036